|
Avaliação DCF de Capricor Therapeutics, Inc. (CAPR)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Capricor Therapeutics, Inc. (CAPR) Bundle
Aprimore suas opções de investimento com a Calculadora DCF da Capricor Therapeutics, Inc. (CAPR)! Explore dados financeiros genuínos, ajuste as projeções e despesas de crescimento e observe instantaneamente como essas variações afetam o valor intrínseco da Capricor Therapeutics, Inc. (CAPR).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0 | .3 | .2 | 2.5 | 25.2 | 32.1 | 40.9 | 52.1 | 66.4 | 84.7 |
| Revenue Growth, % | 0 | -69.13 | -21.06 | 940.81 | 887.79 | 27.45 | 27.45 | 27.45 | 27.45 | 27.45 |
| EBITDA | -7.6 | -13.5 | -20.7 | -29.2 | -23.0 | -31.5 | -40.2 | -51.2 | -65.3 | -83.2 |
| EBITDA, % | -752.41 | -4366.18 | -8449.54 | -1144.18 | -91.39 | -98.28 | -98.28 | -98.28 | -98.28 | -98.28 |
| Depreciation | .2 | .1 | .2 | .7 | 1.1 | 12.5 | 16.0 | 20.3 | 25.9 | 33.0 |
| Depreciation, % | 17.11 | 46.38 | 100.33 | 27.26 | 4.25 | 39 | 39 | 39 | 39 | 39 |
| EBIT | -7.7 | -13.7 | -20.9 | -29.9 | -24.1 | -31.8 | -40.5 | -51.7 | -65.9 | -83.9 |
| EBIT, % | -769.52 | -4412.56 | -8549.86 | -1171.44 | -95.63 | -99.13 | -99.13 | -99.13 | -99.13 | -99.13 |
| Total Cash | 9.9 | 32.7 | 34.9 | 41.4 | 39.5 | 32.1 | 40.9 | 52.1 | 66.4 | 84.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .1 | .4 | .5 | 10.4 | 12.2 | 15.5 | 19.8 | 25.2 | 32.1 |
| Account Receivables, % | 8.75 | 18.05 | 159.96 | 21.48 | 41.19 | 37.9 | 37.9 | 37.9 | 37.9 | 37.9 |
| Inventories | -.7 | -.1 | .0 | .0 | .0 | -5.4 | -6.8 | -8.7 | -11.1 | -14.2 |
| Inventories, % | -65.61 | -18.05 | 0.000408333265 | 0.000039232348 | 0 | -16.73 | -16.73 | -16.73 | -16.73 | -16.73 |
| Accounts Payable | .9 | 2.7 | 3.1 | 4.8 | 6.2 | 26.5 | 33.8 | 43.0 | 54.9 | 69.9 |
| Accounts Payable, % | 88.12 | 875.3 | 1272.52 | 189.68 | 24.72 | 82.57 | 82.57 | 82.57 | 82.57 | 82.57 |
| Capital Expenditure | .0 | -.5 | -1.2 | -3.4 | -2.0 | -19.8 | -25.2 | -32.1 | -40.9 | -52.2 |
| Capital Expenditure, % | 0 | -176.5 | -488.48 | -131.81 | -8.13 | -61.63 | -61.63 | -61.63 | -61.63 | -61.63 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.5 | -13.5 | -20.3 | -29.9 | -24.1 | -31.3 | -39.9 | -50.9 | -64.8 | -82.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -5.8 | -12.7 | -21.2 | -31.0 | -33.5 | -14.7 | -43.8 | -55.8 | -71.1 | -90.6 |
| WACC, % | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 | 23.24 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -133.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -92 | |||||||||
| Terminal Value | -435 | |||||||||
| Present Terminal Value | -153 | |||||||||
| Enterprise Value | -286 | |||||||||
| Net Debt | -12 | |||||||||
| Equity Value | -274 | |||||||||
| Diluted Shares Outstanding, MM | 27 | |||||||||
| Equity Value Per Share | -10.22 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Capricor Therapeutics, Inc.'s (CAPR) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life CAPR Financials: Pre-filled historical and projected data for Capricor Therapeutics, Inc. (CAPR).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Capricor's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Capricor's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Obtain the pre-built Excel file featuring Capricor Therapeutics, Inc. (CAPR) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and instantly analyze different outcomes.
- Make Decisions: Leverage the valuation results to inform your investment strategy.
Why Choose This Calculator for Capricor Therapeutics, Inc. (CAPR)?
- Designed for Industry Experts: A sophisticated tool utilized by biopharmaceutical analysts, investment managers, and researchers.
- Comprehensive Data: Capricor’s historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions to explore potential outcomes.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth and intuitive experience.
Who Should Use This Product?
- Healthcare Students: Understand biopharmaceutical development and apply concepts using real-world data.
- Researchers: Utilize advanced models in academic studies related to regenerative medicine.
- Investors: Evaluate your investment strategies and analyze valuation metrics for Capricor Therapeutics, Inc. (CAPR).
- Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
- Entrepreneurs: Discover how public biotech companies like Capricor Therapeutics, Inc. (CAPR) are evaluated in the market.
What the Template Contains
- Pre-Filled Data: Features Capricor Therapeutics, Inc.'s historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations included.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Capricor's profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily adjust revenue growth, margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.